Publications and Presentations

2017 Coats B.R., Schoenfelt K.Q., Barbosa-Lorenzi V.C., Peris E., Cui C., Hoffman A., Zhou G., Fernandez S., Zhai L., Hall B.A. et al. Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity. Cell Rep. 2017; 20(13): 3149-3161.
2013 Brickley D.R., Agyeman A.S., Kopp R.F., Hall B.A. et al. (2013). Serum- and Glucocorticoid-induced Protein Kinase 1 (SGK1) is Regulated by Store-Operated Ca2+ Entry and Mediates Cytoprotection Against Necrotic Cell Death. J Biol Chem. 288 (45).
2013 Skor M.N., Wonder E.L., Kocherginsky M., Goyal A., Hall B.A., Cai Y., Conzen S.D. (2013). Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 19 (22)
2012 Hall B.A., Kim T.K., Skor M.N., Conzen S.D. (2012). The requirement for mTORC1 in serum and glucocorticoid-regulated kinase 1 (SGK1) activation correlates with ER-alpha expression. Breast Cancer Res Treat, 135 (2).
2012 Gregg B.E., Moore P.C., Demozay D., Hall B.A., Li M., Husain A., Wright A.J., Atkinson M.A. & Rhodes C.J. (2012). Formation of a Baseline Pancreatic ß-Cell Population in Humans is 1 Set Early in Life. J Clin Endocrinol Metab. 97 (9).
2010 Hall B.A., Kim T.K., Skor M.N., Conzen S.D. The Role of Estrogen Receptor Signaling in mTORC Activity (2010). Endo Rev. 31 (3).
2008 Hall B.A. “The identification and characterization of novel serum and glucocorticoid regulated kinase 1 (SGK1) isoforms in human skin” (2008). British Lib 1:615.778.